About Keith Flaherty
Keith Flaherty is a director at Antares Therapeutics.
Form D filings also name Keith Flaherty as a director at Scorpion Therapeutics.
Keith Flaherty first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Keith Flaherty in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Keith Flaherty works with at each company, as listed on that company's latest Form D.
Antares Therapeutics, Inc. · Form D, May 15, 2025
AF
Andrew Fedder
General Counsel
MP
Menelas Pangalos
Director
JA
Jeffrey Albers
Director
JF
Jean-Francois Formela
Director
AF
Adam Friedman
Executive officer and director
BP
Brian Piper
Executive officer
SC
Shelley Chu
Director
Scorpion Therapeutics, Inc. · Form D, Jul 16, 2024
AF
Andrew Fedder
Executive officer
ON
Oleg Nodelman
Director
OS
Otello Stampacchia
Director
AF
Adam Friedman
Chief Executive Officer and director
SC
Shelley Chu
Director
DS
Darrin Stuart
Executive officer
EJ
Erica Jackson
Executive officer
JF
Jean-Francois Formela
Director
AV
Amanda Valentino
Executive officer
JA
Jeffrey Albers
Director
SS
Saurabh Saha
Director
AG
Arjun Goyal
Director
MC
Mark Chao
Executive officer
BP
Brian Piper
Executive officer